⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL8557568 | 0.96 | — | — | |
| SCHEMBL9152652 | 0.87 | GNAI3 (0.41) | — | |
| Hydrazine SCHEMBL8558957 | 0.84 | GNAI3 (0.39) | — | |
| SCHEMBL7294166 | 0.73 | — | — | |
| SCHEMBL4687615 | 0.73 | — | — | |
| SCHEMBL8827681 | 0.70 | L3MBTL1 (0.39) | — | |
| SCHEMBL7518979 | 0.70 | POLB (0.33) | — | |
| SCHEMBL3644949 | 0.69 | — | — | |
| SCHEMBL4829518 | 0.69 | — | — | |
| SCHEMBL1854212 | 0.69 | GAA (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113929642-B | Dehydroabietylamine silver ion fluorescent probe and preparation method thereof | 南京林业大学 | 2023-04-11 | — | — | CN | claimed |
| US-10975092-B2 | Pyrimidine seven-membered-ring compounds, preparation method therefor, pharmaceutical composition thereof, and uses thereof | ANHUI NEW STAR PHARMACEUTICAL DEVELOPMENT CO., LTD. (CN) | 2021-04-13 | — | — | US | claimed |
| US-20200115386-A1 | PYRIMIDINE SEVEN-MEMBERED-RING COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF | Anhui New Star Pharmaceutical Development Co., Ltd . (CN) | 2020-04-16 | — | — | US | claimed |
| EP-3424929-A1 | PYRIMIDINE SEVEN-MEMBERED-RING COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USES THEREOF | Anhui New Star Pharmaceutical Development Co., Ltd (CN) | 2019-01-09 | — | — | EP | claimed |
| CN-104080865-B | Photoresponse binding agent | 湛新比利时股份有限公司 | 2016-06-08 | — | — | CN | claimed |
| CN-122029238-A | Curable composition and cured product | 株式会社钟化 | 2026-05-12 | — | — | CN | disclosed |
| CN-104080865-B | Photoresponse binding agent | 湛新比利时股份有限公司 | 2016-06-08 | — | — | CN | disclosed |
| WO-2012051457-A1 | NUCLEIC ACID DELIVERY COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-04-19 | — | — | WO | disclosed |
| US-20120094924-A1 | NUCLEIC ACID DELIVERY COMPOUNDS | NITTO DENKO CORPORATION (JP) | 2012-04-19 | — | — | US | disclosed |
| US-7998950-B2 | Antiviral compounds | GILEAD SCIENCES, INC. (US) | 2011-08-16 | — | — | US | disclosed |
| US-20100022508-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2010-01-28 | — | — | US | disclosed |
| US-20060135517-A1 | Imidazolopyridines and methods of making and using the same | BIOGEN IDEC MA INC. | 2006-06-22 | — | — | US | disclosed |
| WO-2003051897-A1 | NUCLEOSIDE ANALOG LIBRARIES AND COMPOUNDS | RIBAPHARM INC. (US) | 2003-06-26 | — | — | WO | disclosed |
| WO-2003051896-A1 | CYTIDINE LIBRARIES AND COMPOUNDS SYNTHESIZED BY SOLID-PHASE COMBINATORIAL STRATEGIES | RIBAPHARM INC. (US) | 2003-06-26 | — | — | WO | disclosed |
| US-20020051991-A1 | Rapid generation of diverse nucleoside and nucleotide libraries | HONG ZHI (US) | 2002-05-02 | — | — | US | disclosed |
| EP-0575954-B1 | Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process | MEDIOLANUM FARMACEUTICI SRL (IT) | 1998-09-02 | — | — | EP | disclosed |
| US-5424451-A | Used as cholinesterase activity inhibitors | MEDIOLANUM FARMACEUTICI S.P.A. (IT) | 1995-06-13 | — | — | US | disclosed |
| US-5302593-A | Aminoalkylcarbamic esters of eseroline suitable for use as chlorinesterase activity inhibitors | MEDIOLANUM FARMACEUTICI S.P.A. (IT) | 1994-04-12 | — | — | US | disclosed |
| EP-0575954-A1 | Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process | MEDIOLANUM FARMACEUTICI S.P.A. (IT) | 1993-12-29 | — | — | EP | disclosed |
| EP-0433879-A2 | Aminothiazoles | BASF Aktiengesellschaft (DE) | 1991-06-26 | — | — | EP | disclosed |